Edoardo Mercadante

Prof. Edoardo Mercadante


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2003 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
FVFederico Venuta
Federico Venuta
ERErino A Rendina
Erino A Rendina
FLFlavia Longo
Flavia Longo
TGTiziano De Giacomo
Tiziano De Giacomo
MAMarco Anile
Marco Anile
GCGiorgio F Coloni
Giorgio F Coloni

1 October 2002 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
FVFederico Venuta
Federico Venuta
ERErino A Rendina
Erino A Rendina
TGTiziano De Giacomo
Tiziano De Giacomo
EMEdoardo Mercadante
Edoardo Mercadante
FFFederico Francioni
Federico Francioni
GCGiorgio F Coloni
Giorgio F Coloni

24 February 2024 in European Journal of Internal Medicine
Verified
Journal Article
Open access
LCLuisa Canè
Luisa Canè
Remo PotoRemo Poto
Remo Poto
FPFrancesco Palestra
Francesco Palestra
MPMarinella Pirozzi
Marinella Pirozzi
SPSeetharaman Parashuraman
Seetharaman Parashuraman
Gilda VarricchiGilda Varricchi
Gilda Varricchi
Macrophages are the predominant immune cells in the human lung and play a central role in airway inflammation, including asthma and chronic obstructive pulmonary disease (COPD). Thymic stromal lymphopoietin (TSLP), a pleiotropic cytokine mainly expressed by bronchial epithelial cells, plays a key role in asthma and COPD pathobiology. TSLP exists in two variants: the long form (lfTSLP) and a shorter TSLP isoform (sfTSLP). We aimed to localize TSLP in human lung macrophages (HLMs) and investigate the mechanisms of its release from these cells. We also evaluated the effects of the two variants of TSLP on the release of angiogenic factor from HLMs. We employed immunofluorescence and Western blot to localize intracellular TSLP in HLMs purified from human lung parenchyma. HLMs were activated by T2-high (IL-4, IL-13) and T2-low (lipopolysaccharide: LPS) immunological stimuli. TSLP was detected in HLMs and subcellularly localized in the cytoplasm. IL-4 and LPS induced TSLP release from HLMs. Preincubation of macrophages with brefeldin A, known to disrupt the Golgi apparatus, inhibited TSLP release induced by LPS and IL-4. lfTSLP concentration-dependently induced the release of vascular endothelial growth factor-A (VEGF-A), the most potent angiogenic factor, from HLMs. sfTSLP neither activated nor interfered with the activating property of lfTSLP on macrophages. Our results highlight a novel immunologic circuit between HLMs and TSLP. Given the central role of macrophages in airway inflammation, this autocrine loop holds potential translational relevance in understanding innovative aspects of the pathobiology of asthma and chronic inflammatory lung disorders.

17 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
AOAlessandro Ottaiano
Alessandro Ottaiano
MSMariachiara Santorsola
Mariachiara Santorsola
LCLuisa Circelli
Luisa Circelli
ATAnna Maria Trotta
Anna Maria Trotta
FIFrancesco Izzo
Francesco Izzo
Michele CaragliaMichele Caraglia
Michele Caraglia
Some cancer patients display a less aggressive form of metastatic disease, characterized by a low tumor burden and involving a smaller number of sites, which is referred to as “oligometastatic disease” (OMD). This review discusses new biomarkers, as well as methodological challenges and perspectives characterizing OMD. Recent studies have revealed that specific microRNA profiles, chromosome patterns, driver gene mutations (ERBB2, PBRM1, SETD2, KRAS, PIK3CA, SMAD4), polymorphisms (TCF7L2), and levels of immune cell infiltration into metastases, depending on the tumor type, are associated with an oligometastatic behavior. This suggests that OMD could be a distinct disease with specific biological and molecular characteristics. Therefore, the heterogeneity of initial tumor burden and inclusion of OMD patients in clinical trials pose a crucial methodological question that requires responses in the near future. Additionally, a solid understanding of the molecular and biological features of OMD will be necessary to support and complete the clinical staging systems, enabling a better distinction of metastatic behavior and tailored treatments.

1 June 2003 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
FVFederico Venuta
Federico Venuta
ERErino A Rendina
Erino A Rendina
TGTiziano De Giacomo
Tiziano De Giacomo
ACAnna Maria Ciccone
Anna Maria Ciccone
MMMarco Moretti
Marco Moretti
GCGiorgio F Coloni
Giorgio F Coloni
The 'clamshell incision' is considered the standard approach for bilateral sequential lung transplantation (BSLT); however, a considerable morbidity may be related to this incision. The bilateral anterolateral thoracotomy without sternal division is an alternative approach that may contribute to avoid chest wall complications. We have employed this approach in a prospective series of 34 patients undergoing bilateral transplantation (Group I). The results were retrospectively compared with an historical control group of 37 patients (Group II) undergoing transplantation through the clamshell incision. The operative time in Groups I and II were 228+/-32 and 293+/-37 min, respectively; the difference between the ischemic time of the first and second lungs were 68+/-20 and 73+/-15 min. Intensive care unit stay was 5+/-6 vs. 13+/-10 days and length of hospitalization was 25+/-16 vs. 32+/-10 days. Vital capacity measured 3 weeks after the transplant was significantly higher in Group I (65+/-13 vs. 45+/-8% predicted) as well as FEV(1) (71+/-8 vs. 58+/-7% predicted). No wound related complication was observed in Group I; in Group II, there were 17 chest wall complications: sternal osteomyelitis in three patients (surgical debridement and closure with a muscle flap), migration of the Kirshner wire in three (removal of the wire), sternal override in three (surgical correction) and prolonged pain in eight. The bilateral anterolateral thoracotomy without sternal splitting is a safe and effective approach for BSLT; it allows to avoid sternal complications and contributes to improve respiratory function in the early postoperative period.

1 September 2002 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
TGTiziano De Giacomo
Tiziano De Giacomo
ERErino A Rendina
Erino A Rendina
FVFederico Venuta
Federico Venuta
DLDomenico Lauri
Domenico Lauri
EMEdoardo Mercadante
Edoardo Mercadante
GCGiorgio F Coloni
Giorgio F Coloni